ID: ALA1392694

Max Phase: Preclinical

Molecular Formula: C12H12O4

Molecular Weight: 220.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)C(=O)/C=C(/O)c1ccc(C)cc1

Standard InChI:  InChI=1S/C12H12O4/c1-8-3-5-9(6-4-8)10(13)7-11(14)12(15)16-2/h3-7,13H,1-2H3/b10-7+

Standard InChI Key:  KAQIFZRTEIWJID-JXMROGBWSA-N

Associated Targets(non-human)

Kynurenine 3-monooxygenase 207 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 220.22Molecular Weight (Monoisotopic): 220.0736AlogP: 1.64#Rotatable Bonds: 3
Polar Surface Area: 63.60Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.21CX Basic pKa: CX LogP: 2.56CX LogD: 1.36
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.36Np Likeness Score: -0.05

References

1. Drysdale MJ, Hind SL, Jansen M, Reinhard JF..  (2000)  Synthesis and SAR of 4-aryl-2-hydroxy-4-oxobut-2-enoic acids and esters and 2-amino-4-aryl-4-oxobut-2-enoic acids and esters: potent inhibitors of kynurenine-3-hydroxylase as potential neuroprotective agents.,  43  (1): [PMID:10633043] [10.1021/jm990396t]

Source